Ewing’s Sarcoma is one of three different kinds’ cases of bone cancer. It is usually diagnosed in a younger generation with the victims usually between the ages of ten to twenty years old and the most commonly diagnosed are males. There have been cases of children getting Ewing’s Sarcoma from as young as three or four years of age. It rarely is diagnosed or contracted past the age of thirty years old. It is generally diagnosed in Caucasians and not as often in African-Americans or Asians; in fact it is very rare. It is a highly malignant primary tumor in the bone and is generally found in the Upper legs, hip and pelvis of a patient, although it can occur anywhere in the body. This type of cancer is found inside of the soft tissue in the bone.
Pain radiating from the limbs can be one of the first indicators on bone cancer, especially Ewing’s Sarcoma. This pain begins small and dull and escalates quickly to a very intense feeling. Elevated LDH levels as well as weight loss and anemia also accompany the symptoms of Ewing’s Sarcoma. Tender swelling that is localized and has been apparent for several weeks or months is an indicator that you should visit your doctor for further testing. A cat scan or MRI will be able to diagnose your cancer and will be able to further tell whether or not it has spread to other parts of your body, which will decide the proper course of treatment. Generally, a surgery is performed to remove the cancerous tumor. If the tumor is extremely large, amputation may be a necessity in order to keep the cancer from spreading elsewhere. The surgery is then followed by an extensive round or rounds of radiation or chemotherapy.
Ewing’s Sarcoma is the most lethal and the second most common cancerous or malignant tumor found in a young cancer patient. There is a survival rate of 5 years that is 70%-80% if the bone cancer is found early enough and has not metastasized, or spread and has been treated with chemotherapy. If the cancer has metastasized, the long term survival rate plummets to around 10%-20%.
Article Source: http://EzineArticles.com/?expert=Matt_Murren
